# Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease

> **NCT07496021** · NA · RECRUITING · sponsor: **CKD Bio Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Early Alzheimers Disease

## Interventions

- **DRUG:** L. lactis CKDB001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07496021
- **Lead sponsor:** CKD Bio Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-23
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07496021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07496021, "Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07496021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*